<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<rss version="2.0">
  <channel>
    <title>Reviews in the Neurosciences</title>
    <link>www.degruyter.com</link>
    <description/>
    <item>
      <title>Frontmatter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-frontmatter5/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-frontmatter5/html</guid>
    </item>
    <item>
      <title>Dendritic spines and their role in the pathogenesis of neurodevelopmental and neurological disorders</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0151/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0151/html</guid>
    </item>
    <item>
      <title>Mitochondria and MICOS – function and modeling</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0004/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0004/html</guid>
    </item>
    <item>
      <title>The role of long noncoding RNAs in amyotrophic lateral sclerosis</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0155/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0155/html</guid>
    </item>
    <item>
      <title>Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0010/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0010/html</guid>
    </item>
    <item>
      <title>Analysis of radiological features in patients with post-stroke depression and cognitive impairment</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0120/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0120/html</guid>
    </item>
    <item>
      <title>Impact of carotid stenosis on the outcome of stroke patients submitted to reperfusion treatments: a narrative review</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0002/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0002/html</guid>
    </item>
    <item>
      <title>Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer’s disease</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0007/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0007/html</guid>
    </item>
  </channel>
</rss>
